Ashley & Martin, the largest medical hair
clinic in the southern hemisphere

Clinical Studies and Awards

RealGROWTH treatment studies

An ambitious study was conducted early last decade on the success of the RealGROWTH treatment regime. Patients were selected who had genetic male pattern baldness and who had hair loss that had occurred for less than seven years. Each patient had 4 small dots tattooed in the hair thinning area, using a surgical marker to join the dots a square was formed. Each patient was reviewed by a dermatologist every month, with each square being photographed and each hair strand counted. After 6 months the final result showed that every patient responded with more hair. The overall increase in density was between 30% and 215%, average result obtained was 113% more hair density. Since this initial study we then had Nielson review 200 patients. They contacted the patients and conducted an interview with each one. Out of these interviews it was shown that 98% of patients confirmed more hair regrowth. From this period onwards Ashley and Martin started to offer patients a guarantee on regrowth of hair if they so desired. Every year since we have calculated the success rate based on refunds verses programs completed. The result has always been around the 98% mark with tens of thousands of patients going through this system.

Lasercap studies

Lasercap® initiated a 2 year informal Lasercap® clinical trial study in March 2013 which is being conducted by the company’s Physician Advisory Group. More than 70 patients are enrolled in this study and their progress is being evaluated over a period of 2 years using Global photographic evaluations by blinded physicians and detailed case study reports by individual doctors.

Summary on 6-month photographic evaluation: “These results are highly supportive of efficacy of LaserCap® in just 90 to 120 days with the current treatment protocol. Evidence of Global Photographic improvement in 44% of subjects is comparable or superior to improvement seen in subject in therapeutic pharmacologic studies. 53% were assessed as ‘No change’ and only 3% was assessed as ‘Worse’. Additional evaluations will be performed on subjects continuing on LaserCap® treatment for up to 12 months.”Robert Haber, MD

Ashley and Martin have been utilising the LaserCap device for well over 18 months and we would state that the success rate is higher as you get closer to the 12 month mark.

Superbrand award

Ashley and Martin became the first and only company in the hair loss industry to receive the Superbrand accolade.

The award is based on the following grading criteria:

• Market dominance
Does the brand hold a significant share of the market for its goods and / or services?

• Longevity
Does the brand possess or display the qualities and attributes necessary to make it resilient to negative market influences?

• Goodwill
Is the brand generally perceived favourably by consumers and is it accepted without question or reservation?

• Customer loyalty
Will the brand’s consumers choose it repeatedly and automatically over competing brands?

• Overall market acceptance
Is the brand a part of everyday life for the relevant market segment, and is it automatically on the consumer’s list of choices for that product or service?